Agios Pharmaceuticals | AGIO - Les Intérêts Débiteurs Sur La Dette

Prix De L'Action
25.32
Variation Quotidienne
-0.42 -1.63%
Mensuellement
-14.43%
Annuel
-14.02%
Q2 Prévisions
24.78




Les Intérêts Débiteurs Sur La Dette Changement Date
AbbVie USD 740M 40M 2025-06
Agios Pharmaceuticals USD 1.39B 85.53M 2025-09
Alnylam Pharmaceuticals USD 129.34M 84.94M 2025-12
Amgen USD 653M 32M 2025-12
Arrowhead Research USD 22.5M 811K 2025-12
Astellas Pharma JPY 3.91B 320M 2025-03
AstraZeneca USD 484M 181M 2025-12
Bayer EUR 675M 87M 2025-12
Biogen USD 72.6M 12.6M 2025-06
BioMarin Pharmaceutical USD 2.78M 199K 2025-12
Bristol-Myers Squibb USD 432M 48M 2025-12
Daiichi Sankyo JPY 2.16B 1.33B 2025-12
Eli Lilly USD 114.7M 134.3M 2025-09
Exelixis USD 23.4M 3.9M 2023-09
Gilead Sciences USD 255M 1000K 2025-12
GlaxoSmithKline GBP 188M 21M 2025-12
Incyte USD 582K 10K 2025-12
Ionis Pharmaceuticals USD 18M 0 2025-12
Merck USD 412M 85M 2025-12
Moderna USD 12.14B 12.13B 2025-09
Nektar Therapeutics USD 9.77M 3.75M 2025-12
Novartis USD 304M 23M 2025-12
Novartis USD 281M 8M 2025-09
Pfizer USD 711M 59M 2025-12
Puma Biotechnology USD 3.37M 11K 2024-06
Regeneron Pharmaceuticals USD 12.2M 7.1M 2025-12
Roche Holding CHF 304M 7.5M 2025-06
Sarepta Therapeutics USD 7.56M 2.33M 2025-09
Vertex Pharmaceuticals USD 3.3M 0 2025-12